These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21245274)

  • 41. Role of microbiota and innate immunity in recurrent Clostridium difficile infection.
    Bibbò S; Lopetuso LR; Ianiro G; Di Rienzo T; Gasbarrini A; Cammarota G
    J Immunol Res; 2014; 2014():462740. PubMed ID: 24995345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clostridium difficile flagella predominantly activate TLR5-linked NF-κB pathway in epithelial cells.
    Batah J; Denève-Larrazet C; Jolivot PA; Kuehne S; Collignon A; Marvaud JC; Kansau I
    Anaerobe; 2016 Apr; 38():116-124. PubMed ID: 26790921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen.
    Hasegawa M; Yamazaki T; Kamada N; Tawaratsumida K; Kim YG; Núñez G; Inohara N
    J Immunol; 2011 Apr; 186(8):4872-80. PubMed ID: 21411735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toll-like receptor 5-deficient mice have dysregulated intestinal gene expression and nonspecific resistance to Salmonella-induced typhoid-like disease.
    Vijay-Kumar M; Aitken JD; Kumar A; Neish AS; Uematsu S; Akira S; Gewirtz AT
    Infect Immun; 2008 Mar; 76(3):1276-81. PubMed ID: 18195036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunization using GroEL decreases Clostridium difficile intestinal colonization.
    Péchiné S; Hennequin C; Boursier C; Hoys S; Collignon A
    PLoS One; 2013; 8(11):e81112. PubMed ID: 24303034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation.
    Rhee SH; Im E; Riegler M; Kokkotou E; O'brien M; Pothoulakis C
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13610-5. PubMed ID: 16157881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of interferon-γ and inflammatory monocytes in driving colonic inflammation during acute Clostridium difficile infection in mice.
    McDermott AJ; Falkowski NR; McDonald RA; Frank CR; Pandit CR; Young VB; Huffnagle GB
    Immunology; 2017 Apr; 150(4):468-477. PubMed ID: 27995603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human Plasminogen Exacerbates Clostridioides difficile Enteric Disease and Alters the Spore Surface.
    Awad MM; Hutton ML; Quek AJ; Klare WP; Mileto SJ; Mackin K; Ly D; Oorschot V; Bosnjak M; Jenkin G; Conroy PJ; West N; Fulcher A; Costin A; Day CJ; Jennings MP; Medcalf RL; Sanderson-Smith M; Cordwell SJ; Law RHP; Whisstock JC; Lyras D
    Gastroenterology; 2020 Oct; 159(4):1431-1443.e6. PubMed ID: 32574621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epithelial toll-like receptor 5 is constitutively localized in the mouse cecum and exhibits distinctive down-regulation during experimental colitis.
    Ortega-Cava CF; Ishihara S; Rumi MA; Aziz MM; Kazumori H; Yuki T; Mishima Y; Moriyama I; Kadota C; Oshima N; Amano Y; Kadowaki Y; Ishimura N; Kinoshita Y
    Clin Vaccine Immunol; 2006 Jan; 13(1):132-8. PubMed ID: 16426010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a Standardized Scoring System to Assess a Murine Model of
    Shelby RD; Tengberg N; Conces M; Olson JK; Navarro JB; Bailey MT; Goodman SD; Besner GE
    J Invest Surg; 2020 Dec; 33(10):887-895. PubMed ID: 30892111
    [No Abstract]   [Full Text] [Related]  

  • 51. Proton-Pump Inhibitor Exposure Aggravates Clostridium difficile-Associated Colitis: Evidence From a Mouse Model.
    Hung YP; Ko WC; Chou PH; Chen YH; Lin HJ; Liu YH; Tsai HW; Lee JC; Tsai PJ
    J Infect Dis; 2015 Aug; 212(4):654-63. PubMed ID: 25805751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Host recognition of Clostridium difficile and the innate immune response.
    Cowardin CA; Petri WA
    Anaerobe; 2014 Dec; 30():205-9. PubMed ID: 25223264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile.
    Bruxelle JF; Mizrahi A; Hoÿs S; Collignon A; Janoir C; Péchiné S
    PLoS One; 2017; 12(11):e0187212. PubMed ID: 29176760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deletion of TLR5 results in spontaneous colitis in mice.
    Vijay-Kumar M; Sanders CJ; Taylor RT; Kumar A; Aitken JD; Sitaraman SV; Neish AS; Uematsu S; Akira S; Williams IR; Gewirtz AT
    J Clin Invest; 2007 Dec; 117(12):3909-21. PubMed ID: 18008007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The American Cockroach Peptide Periplanetasin-2 Blocks
    Hong J; Zhang P; Yoon IN; Hwang JS; Kang JK; Kim H
    J Microbiol Biotechnol; 2017 Apr; 27(4):694-700. PubMed ID: 28173695
    [No Abstract]   [Full Text] [Related]  

  • 56. Epithelial cell I kappa B-kinase beta has an important protective role in Clostridium difficile toxin A-induced mucosal injury.
    Chae S; Eckmann L; Miyamoto Y; Pothoulakis C; Karin M; Kagnoff MF
    J Immunol; 2006 Jul; 177(2):1214-20. PubMed ID: 16818780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts.
    Lawley TD; Clare S; Walker AW; Goulding D; Stabler RA; Croucher N; Mastroeni P; Scott P; Raisen C; Mottram L; Fairweather NF; Wren BW; Parkhill J; Dougan G
    Infect Immun; 2009 Sep; 77(9):3661-9. PubMed ID: 19564382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TRIF mediates Toll-like receptor 5-induced signaling in intestinal epithelial cells.
    Choi YJ; Im E; Chung HK; Pothoulakis C; Rhee SH
    J Biol Chem; 2010 Nov; 285(48):37570-8. PubMed ID: 20855887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study.
    Castex F; Corthier G; Jouvert S; Elmer GW; Lucas F; Bastide M
    J Gen Microbiol; 1990 Jun; 136(6):1085-9. PubMed ID: 2200843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.
    Wang J; Ghali S; Xu C; Mussatto CC; Ortiz C; Lee EC; Tran DH; Jacobs JP; Lagishetty V; Faull KF; Moller T; Rossetti M; Chen X; Koon HW
    Gastroenterology; 2018 May; 154(6):1737-1750. PubMed ID: 29360463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.